Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury
• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macro...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Rangon, Claire-Marie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor - Al Naim, Abdullah F. ELSEVIER, 2022, Orlando, Fla. [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:74 ; year:2018 ; pages:265-276 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.bbi.2018.09.017 |
|---|
| Katalog-ID: |
ELV045167680 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV045167680 | ||
| 003 | DE-627 | ||
| 005 | 20230624113855.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190205s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbi.2018.09.017 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica |
| 035 | |a (DE-627)ELV045167680 | ||
| 035 | |a (ELSEVIER)S0889-1591(18)30295-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.00 |2 bkl | ||
| 084 | |a 51.50 |2 bkl | ||
| 084 | |a 58.00 |2 bkl | ||
| 100 | 1 | |a Rangon, Claire-Marie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| 264 | 1 | |c 2018 | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. | ||
| 650 | 7 | |a Neuroprotection |2 Elsevier | |
| 650 | 7 | |a Prematurity |2 Elsevier | |
| 650 | 7 | |a Oligodendrocyte |2 Elsevier | |
| 650 | 7 | |a Encephalopathy |2 Elsevier | |
| 650 | 7 | |a Neuroinflammation |2 Elsevier | |
| 700 | 1 | |a Schang, Anne-Laure |4 oth | |
| 700 | 1 | |a Van Steenwinckel, Juliette |4 oth | |
| 700 | 1 | |a Schwendimann, Leslie |4 oth | |
| 700 | 1 | |a Lebon, Sophie |4 oth | |
| 700 | 1 | |a Fu, Tingting |4 oth | |
| 700 | 1 | |a Chen, Libo |4 oth | |
| 700 | 1 | |a Beneton, Veronique |4 oth | |
| 700 | 1 | |a Journiac, Nathalie |4 oth | |
| 700 | 1 | |a Young-Ten, Pierrette |4 oth | |
| 700 | 1 | |a Bourgeois, Thomas |4 oth | |
| 700 | 1 | |a Maze, Johanna |4 oth | |
| 700 | 1 | |a Matrot, Boris |4 oth | |
| 700 | 1 | |a Baburamani, Ana A. |4 oth | |
| 700 | 1 | |a Supramaniam, Veena |4 oth | |
| 700 | 1 | |a Mallard, Carina |4 oth | |
| 700 | 1 | |a Trottet, Lionel |4 oth | |
| 700 | 1 | |a Edwards, A. David |4 oth | |
| 700 | 1 | |a Hagberg, Henrik |4 oth | |
| 700 | 1 | |a Fleiss, Bobbi |4 oth | |
| 700 | 1 | |a Li, Jingjun |4 oth | |
| 700 | 1 | |a Chuang, Tsu Tshen |4 oth | |
| 700 | 1 | |a Gressens, Pierre |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Al Naim, Abdullah F. ELSEVIER |t A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |d 2022 |g Orlando, Fla. [u.a.] |w (DE-627)ELV008146462 |
| 773 | 1 | 8 | |g volume:74 |g year:2018 |g pages:265-276 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bbi.2018.09.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
| 936 | b | k | |a 51.50 |j Metallische Werkstoffe: Allgemeines |q VZ |
| 936 | b | k | |a 58.00 |j Chemische Technik: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 74 |j 2018 |h 265-276 |g 12 | ||
| author_variant |
c m r cmr |
|---|---|
| matchkey_str |
rangonclairemarieschangannelaurevansteen:2018----:ylntoidcinyhsaie3eetrnaoitnmueoeo |
| hierarchy_sort_str |
2018 |
| bklnumber |
35.00 51.50 58.00 |
| publishDate |
2018 |
| allfields |
10.1016/j.bbi.2018.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica (DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 DE-627 ger DE-627 rakwb eng 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Rangon, Claire-Marie verfasserin aut Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury 2018 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier Schang, Anne-Laure oth Van Steenwinckel, Juliette oth Schwendimann, Leslie oth Lebon, Sophie oth Fu, Tingting oth Chen, Libo oth Beneton, Veronique oth Journiac, Nathalie oth Young-Ten, Pierrette oth Bourgeois, Thomas oth Maze, Johanna oth Matrot, Boris oth Baburamani, Ana A. oth Supramaniam, Veena oth Mallard, Carina oth Trottet, Lionel oth Edwards, A. David oth Hagberg, Henrik oth Fleiss, Bobbi oth Li, Jingjun oth Chuang, Tsu Tshen oth Gressens, Pierre oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:74 year:2018 pages:265-276 extent:12 https://doi.org/10.1016/j.bbi.2018.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 74 2018 265-276 12 |
| spelling |
10.1016/j.bbi.2018.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica (DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 DE-627 ger DE-627 rakwb eng 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Rangon, Claire-Marie verfasserin aut Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury 2018 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier Schang, Anne-Laure oth Van Steenwinckel, Juliette oth Schwendimann, Leslie oth Lebon, Sophie oth Fu, Tingting oth Chen, Libo oth Beneton, Veronique oth Journiac, Nathalie oth Young-Ten, Pierrette oth Bourgeois, Thomas oth Maze, Johanna oth Matrot, Boris oth Baburamani, Ana A. oth Supramaniam, Veena oth Mallard, Carina oth Trottet, Lionel oth Edwards, A. David oth Hagberg, Henrik oth Fleiss, Bobbi oth Li, Jingjun oth Chuang, Tsu Tshen oth Gressens, Pierre oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:74 year:2018 pages:265-276 extent:12 https://doi.org/10.1016/j.bbi.2018.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 74 2018 265-276 12 |
| allfields_unstemmed |
10.1016/j.bbi.2018.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica (DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 DE-627 ger DE-627 rakwb eng 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Rangon, Claire-Marie verfasserin aut Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury 2018 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier Schang, Anne-Laure oth Van Steenwinckel, Juliette oth Schwendimann, Leslie oth Lebon, Sophie oth Fu, Tingting oth Chen, Libo oth Beneton, Veronique oth Journiac, Nathalie oth Young-Ten, Pierrette oth Bourgeois, Thomas oth Maze, Johanna oth Matrot, Boris oth Baburamani, Ana A. oth Supramaniam, Veena oth Mallard, Carina oth Trottet, Lionel oth Edwards, A. David oth Hagberg, Henrik oth Fleiss, Bobbi oth Li, Jingjun oth Chuang, Tsu Tshen oth Gressens, Pierre oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:74 year:2018 pages:265-276 extent:12 https://doi.org/10.1016/j.bbi.2018.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 74 2018 265-276 12 |
| allfieldsGer |
10.1016/j.bbi.2018.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica (DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 DE-627 ger DE-627 rakwb eng 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Rangon, Claire-Marie verfasserin aut Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury 2018 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier Schang, Anne-Laure oth Van Steenwinckel, Juliette oth Schwendimann, Leslie oth Lebon, Sophie oth Fu, Tingting oth Chen, Libo oth Beneton, Veronique oth Journiac, Nathalie oth Young-Ten, Pierrette oth Bourgeois, Thomas oth Maze, Johanna oth Matrot, Boris oth Baburamani, Ana A. oth Supramaniam, Veena oth Mallard, Carina oth Trottet, Lionel oth Edwards, A. David oth Hagberg, Henrik oth Fleiss, Bobbi oth Li, Jingjun oth Chuang, Tsu Tshen oth Gressens, Pierre oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:74 year:2018 pages:265-276 extent:12 https://doi.org/10.1016/j.bbi.2018.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 74 2018 265-276 12 |
| allfieldsSound |
10.1016/j.bbi.2018.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica (DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 DE-627 ger DE-627 rakwb eng 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Rangon, Claire-Marie verfasserin aut Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury 2018 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier Schang, Anne-Laure oth Van Steenwinckel, Juliette oth Schwendimann, Leslie oth Lebon, Sophie oth Fu, Tingting oth Chen, Libo oth Beneton, Veronique oth Journiac, Nathalie oth Young-Ten, Pierrette oth Bourgeois, Thomas oth Maze, Johanna oth Matrot, Boris oth Baburamani, Ana A. oth Supramaniam, Veena oth Mallard, Carina oth Trottet, Lionel oth Edwards, A. David oth Hagberg, Henrik oth Fleiss, Bobbi oth Li, Jingjun oth Chuang, Tsu Tshen oth Gressens, Pierre oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:74 year:2018 pages:265-276 extent:12 https://doi.org/10.1016/j.bbi.2018.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 74 2018 265-276 12 |
| language |
English |
| source |
Enthalten in A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor Orlando, Fla. [u.a.] volume:74 year:2018 pages:265-276 extent:12 |
| sourceStr |
Enthalten in A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor Orlando, Fla. [u.a.] volume:74 year:2018 pages:265-276 extent:12 |
| format_phy_str_mv |
Article |
| bklname |
Chemie: Allgemeines Metallische Werkstoffe: Allgemeines Chemische Technik: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
Neuroprotection Prematurity Oligodendrocyte Encephalopathy Neuroinflammation |
| dewey-raw |
540 |
| isfreeaccess_bool |
false |
| container_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
| authorswithroles_txt_mv |
Rangon, Claire-Marie @@aut@@ Schang, Anne-Laure @@oth@@ Van Steenwinckel, Juliette @@oth@@ Schwendimann, Leslie @@oth@@ Lebon, Sophie @@oth@@ Fu, Tingting @@oth@@ Chen, Libo @@oth@@ Beneton, Veronique @@oth@@ Journiac, Nathalie @@oth@@ Young-Ten, Pierrette @@oth@@ Bourgeois, Thomas @@oth@@ Maze, Johanna @@oth@@ Matrot, Boris @@oth@@ Baburamani, Ana A. @@oth@@ Supramaniam, Veena @@oth@@ Mallard, Carina @@oth@@ Trottet, Lionel @@oth@@ Edwards, A. David @@oth@@ Hagberg, Henrik @@oth@@ Fleiss, Bobbi @@oth@@ Li, Jingjun @@oth@@ Chuang, Tsu Tshen @@oth@@ Gressens, Pierre @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008146462 |
| dewey-sort |
3540 |
| id |
ELV045167680 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045167680</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624113855.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bbi.2018.09.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045167680</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0889-1591(18)30295-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rangon, Claire-Marie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuroprotection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prematurity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oligodendrocyte</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuroinflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schang, Anne-Laure</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Steenwinckel, Juliette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schwendimann, Leslie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lebon, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fu, Tingting</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Libo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beneton, Veronique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Journiac, Nathalie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Young-Ten, Pierrette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourgeois, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maze, Johanna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matrot, Boris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baburamani, Ana A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Supramaniam, Veena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mallard, Carina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trottet, Lionel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Edwards, A. David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hagberg, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fleiss, Bobbi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Jingjun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chuang, Tsu Tshen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gressens, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Al Naim, Abdullah F. ELSEVIER</subfield><subfield code="t">A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor</subfield><subfield code="d">2022</subfield><subfield code="g">Orlando, Fla. [u.a.]</subfield><subfield code="w">(DE-627)ELV008146462</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:74</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:265-276</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bbi.2018.09.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.50</subfield><subfield code="j">Metallische Werkstoffe: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.00</subfield><subfield code="j">Chemische Technik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">74</subfield><subfield code="j">2018</subfield><subfield code="h">265-276</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| author |
Rangon, Claire-Marie |
| spellingShingle |
Rangon, Claire-Marie ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| authorStr |
Rangon, Claire-Marie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008146462 |
| format |
electronic Article |
| dewey-ones |
540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation Elsevier |
| topic |
ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation |
| topic_unstemmed |
ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation |
| topic_browse |
ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Neuroprotection Elsevier Prematurity Elsevier Oligodendrocyte Elsevier Encephalopathy Elsevier Neuroinflammation |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a l s als s j v sj sjv l s ls s l sl t f tf l c lc v b vb n j nj p y t pyt t b tb j m jm b m bm a a b aa aab v s vs c m cm l t lt a d e ad ade h h hh b f bf j l jl t t c tt ttc p g pg |
| hierarchy_parent_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
| hierarchy_parent_id |
ELV008146462 |
| dewey-tens |
540 - Chemistry |
| hierarchy_top_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008146462 |
| title |
Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| ctrlnum |
(DE-627)ELV045167680 (ELSEVIER)S0889-1591(18)30295-2 |
| title_full |
Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| author_sort |
Rangon, Claire-Marie |
| journal |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
| journalStr |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
265 |
| author_browse |
Rangon, Claire-Marie |
| container_volume |
74 |
| physical |
12 |
| class |
540 VZ 35.00 bkl 51.50 bkl 58.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Rangon, Claire-Marie |
| doi_str_mv |
10.1016/j.bbi.2018.09.017 |
| dewey-full |
540 |
| title_sort |
myelination induction by a histamine h3 receptor antagonist in a mouse model of preterm white matter injury |
| title_auth |
Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| abstract |
• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. |
| abstractGer |
• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. |
| abstract_unstemmed |
• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury |
| url |
https://doi.org/10.1016/j.bbi.2018.09.017 |
| remote_bool |
true |
| author2 |
Schang, Anne-Laure Van Steenwinckel, Juliette Schwendimann, Leslie Lebon, Sophie Fu, Tingting Chen, Libo Beneton, Veronique Journiac, Nathalie Young-Ten, Pierrette Bourgeois, Thomas Maze, Johanna Matrot, Boris Baburamani, Ana A. Supramaniam, Veena Mallard, Carina Trottet, Lionel Edwards, A. David Hagberg, Henrik Fleiss, Bobbi Li, Jingjun Chuang, Tsu Tshen Gressens, Pierre |
| author2Str |
Schang, Anne-Laure Van Steenwinckel, Juliette Schwendimann, Leslie Lebon, Sophie Fu, Tingting Chen, Libo Beneton, Veronique Journiac, Nathalie Young-Ten, Pierrette Bourgeois, Thomas Maze, Johanna Matrot, Boris Baburamani, Ana A. Supramaniam, Veena Mallard, Carina Trottet, Lionel Edwards, A. David Hagberg, Henrik Fleiss, Bobbi Li, Jingjun Chuang, Tsu Tshen Gressens, Pierre |
| ppnlink |
ELV008146462 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.bbi.2018.09.017 |
| up_date |
2024-07-06T16:47:36.491Z |
| _version_ |
1803848994254749696 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045167680</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624113855.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bbi.2018.09.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001886.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045167680</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0889-1591(18)30295-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rangon, Claire-Marie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Preterm born infants (PBI) often suffer white matter injury (WMI); we lack therapies. • Histamine receptor (HR) antagonists improve WMI in multiple sclerosis models. • In a model of the WMI in PBI a H3R antagonist reduces early and long term injury. • Improvements included reduced micro- and macrogliosis and increased myelination. • H3R therapy is effective even though it was started 48 h after WMI was initiated.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuroprotection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prematurity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oligodendrocyte</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuroinflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schang, Anne-Laure</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Steenwinckel, Juliette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schwendimann, Leslie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lebon, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fu, Tingting</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Libo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beneton, Veronique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Journiac, Nathalie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Young-Ten, Pierrette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourgeois, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maze, Johanna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matrot, Boris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baburamani, Ana A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Supramaniam, Veena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mallard, Carina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trottet, Lionel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Edwards, A. David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hagberg, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fleiss, Bobbi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Jingjun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chuang, Tsu Tshen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gressens, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Al Naim, Abdullah F. ELSEVIER</subfield><subfield code="t">A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor</subfield><subfield code="d">2022</subfield><subfield code="g">Orlando, Fla. [u.a.]</subfield><subfield code="w">(DE-627)ELV008146462</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:74</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:265-276</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bbi.2018.09.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.50</subfield><subfield code="j">Metallische Werkstoffe: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.00</subfield><subfield code="j">Chemische Technik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">74</subfield><subfield code="j">2018</subfield><subfield code="h">265-276</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| score |
7.4032135 |